Pharma major Dr Reddy’s Laboratories announced the launch of Nise D spray, which offers quick and targeted pain killing.
Strengthening its over the counter (OTC) portfolio, via this product, Dr. Reddy’s has further expanded its offerings in the therapeutic area of pain relief to consumers, the company said in a statement.
In India, the market for pain relief products is approximately Rs 1,700 crore. Pain relief sprays are growing 20 times faster than creams and gels, indicating a trend of changing consumer preferences.
The formulation for Nise D Spray comprises three key ingredients which get absorbed quicker, penetrate deep to reach the source of pain and reduce inflammation. Nise, as a brand has been providing effective relief to consumers by killing pain over the years.
“Nise D Spray marks our entry into the new segment and further boosts our OTC portfolio. Nise gel has made a remarkable headway into the market and looking at the market dynamics and consumer requirements, we expect Nise D Spray to have a great momentum and significant market share across regions,” said Dr Reddy’s utive vice president and head, branded markets (India & Emerging countries) M V Ramana.
Like
Dislike
Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.
